BioScale installs ViBE analytical tool at Massachusetts-based pharmaceutical company

NewsGuard 100/100 Score

BioScale Inc., an innovative life science company that develops, manufactures and promotes novel analytical tools enabling advancements in protein research, today announced the first shipment and installation of the ViBE™ Protein Analysis Workstation at a major Massachusetts-based pharmaceutical company. The ViBE Workstation will be used in support of oncology programs involving the discovery and validation of biomarkers associated with cancers.

“We at BioScale are pleased for the opportunity to support one of the world's leading oncology-focused pharmaceutical companies in its biomarker research efforts”

"We at BioScale are pleased for the opportunity to support one of the world's leading oncology-focused pharmaceutical companies in its biomarker research efforts," said Mark Lundstrom, Chief Executive Officer at BioScale. "We expect the pace of research into complex diseases like cancer, diabetes, and Alzheimers will accelerate considerably as researchers uncover biomarkers that elucidate the diagnosis and improve treatment options. We believe the power and performance of the ViBE platform will allow pharmaceutical and biotech companies to cut drug discovery and development times and, one day, allow physicians to personalize treatments and provide more informative diagnostic tests."

Chip Leveille, Chief Operating Officer at BioScale commented, "This shipment of the ViBE Workstation represents a major milestone for BioScale. It exemplifies the power of AMMP Technology and the ViBE Platform to those driving innovation in biomarker discovery and development. The simplicity and flexibility of the ViBE platform will provide scientists the ability to perform a wide range of protein analysis not only with more sensitive, reproducible data, but with the power to work in complex samples more quickly and efficiently than ever before."

Powered by AMMP Technology, the ViBE platform enables advancements in protein research. AMMP (Acoustic Membrane MicroParticle) technology is a unique mechanical integration of magnetic microparticles, a universal sensor and acoustic science delivering a proprietary, non-optical protein detection and quantitation technique that is highly robust and versatile, with ease of methods transfer from traditional assay formats. The ViBE Workstation is the ideal tool for reliable, unattended sample analysis including reagent additions, incubation and real-time results with walkaway operation and is well suited for a variety of applications including biomarker discovery and development, bioprocess engineering and manufacturing.

Source:

BioScale

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
The Lancet Breast Cancer Commission: Tackling inequalities, hidden costs, and empowering patients